Sympathetic Overactivity in Patients with Chronic Renal Failure

New England Journal of Medicine

Volumn 327, Issue 27, 1992, Pages 1912-1918

  Converse, Richard L ^a   Jacobsen, Tage N ^a   Toto, Robert D ^a   Jost, Charles M t ^a   Cosentino, Frank ^b   Fouad Tarazi, Fetnat ^b   Victor, Ronald G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN; POSTSYNAPTIC RECEPTOR; RENIN;

ADRENERGIC STIMULATION; ADULT; ARTERIAL PRESSURE; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; MALE; NEPHRECTOMY; NERVE CONDUCTION; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; VASCULAR RESISTANCE;

ANGIOTENSIN II; FEMALE; HUMAN; HYPERTENSION; KIDNEY; KIDNEY FAILURE, CHRONIC; LEG; MALE; MIDDLE AGE; NEPHRECTOMY; NOREPINEPHRINE; PERONEAL NERVE; RENAL DIALYSIS; RENIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SYMPATHETIC NERVOUS SYSTEM; VASCULAR RESISTANCE;

EID: 0027075024     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199212313272704     Document Type: Article

References (40)

1. Rostand SG, Brunzell JD, Cannon RO III, Victor RG. Cardiovascular complications in renal failure. J Am Soc Nephrol 1991; 2: 1053–62.
2. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697–701.
3. Zucchelli P, Zuccala A. Control of blood pressure in patients on haemodialysis. In: Cameron S, Davison AM, Grünfeld JP, Kerr D, Ritz E, eds. Oxford textbook of clinical nephrology. Vol. 2. Oxford, England: Oxford University Press, 1992:1458–67.
4. Lazarus JM, Hampers CL, Lowrie EG, Merrill JP. Baroreceptor activity in normotensive and hypertensive uremic patients. Circulation 1973; 47: 1015–21.
5. Zucchelli P, Santoro A, Zuccala A. Genesis and control of hypertension in hemodialysis patients. Semin Nephrol 1988; 8: 163–8.
6. Lilley JJ, Golden J, Stone RA. Adrenergic regulation of blood pressure in chronic renal failure. J Clin Invest 1976; 57: 1190–200.
7. Henrich WL, Katz FH, Molinoff PB, Schreir RW. Competitive effects of hypokalemia and volume depletion on plasma renin activity, aldosterone and catecholamine concentrations in hemodialysis patients. Kidney Int 1977; 12: 279–84.
8. White RP, Sealey J, Reidenberg M, et al. Mechanisms of blood pressure control in anephrics: plasma renin and dopamine β hydroxylase activity. Trans Am Soc Artif Intern Organs 1976; 22: 420–2.
9. McGrath BP, Tiller DJ, Bune A, Chalmers JP, Korner PI, Uther JB. Autonomic blockade and the Valsalva maneuver in patients on maintenance hemodialysis: a hemodynamic study. Kidney Int 1977; 12: 294–302.
10. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 1981; 20: 246–53.
11. Cuche J-L, Prinseau J, Selz F, Ruget G, Baglin A. Plasma free, sulfo- and glucuro-conjugated catecholamines in uremic patients. Kidney Int 1986; 30: 566–72.
12. Degli Esposti E, Sturani A, Zuccalà A, Chiarini C, Zucchelli P. Effect of bromocriptine treatment on prolactin, noradrenaline and blood pressure in hypertensive haemodialysis patients. Clin Sci 1985; 69: 51–6.
13. Weidmann P, Schohn D, Laederach K, Uehlinger DE, Gnadinger MP, Shaw S. Catecholamines and their possible role in hypertension associated with impaired renal function. Contrib Nephrol 1987; 54: 159–76.
14. Katholi RE, Whitlow PL, Hageman GR, Woods WT. Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertens 1984; 2: 349–59.
15. Recordati G, Moss NG, Genovesi S, Rogenes P. Renal chemoreceptors. J Auton Nerv Syst 1981; 3: 237–51.
16. DiBona GF. The function of the renal nerves. Rev Physiol Biochem Pharmacol 1982; 94: 76–181.
17. Faber JE, Brody MJ. Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat. Circ Res 1985; 57: 676–88.
18. Katholi RE, Winternitz SR, Oparil S. Decrease in peripheral sympathetic nervous system activity following renal denervation or unclipping in the one-kidney one-clip Goldblatt hypertensive rat. J Clin Invest 1982; 69: 55–62.
19. Vallbo AB, Hagbarth K-E, Torebjörk HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979; 59: 919–57.
20. Delius W, Hagbarth K-E, Hongell A, Wallin BG. Manoeuvres affecting sympathetic outflow in human muscle nerves. Acta Physiol Scand 1972; 84: 82–94.
21. Mark AL, Victor RG, Nerhed C, Wallin BG. Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res 1985; 57: 461–9.
22. Siggaard-Andersen J. Venous occlusion plethysmography on the calf: evaluation of diagnosis and results in vascular surgery. Dan Med Bull 1970; 17: Suppl I: 1–68.
23. Peuler JD, Johnson GA. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 1977; 21: 625–36.
24. Bravo EL, Tarazi RC, Dustan HP. β-Adrenergic blockade in diuretic-treated patients with essential hypertension. N Engl J Med 1975; 292: 66–70.
25. Suzuki H, Ferrario CM, Speth RC, Brosnihan KB, Smeby RR, de Silva P. Alterations in plasma and cerebrospinal fluid norepinephrine and angiotensin II during the development of renal hypertension in conscious dogs. Hypertension 1983; 5: Suppl I: I-139—I-148.
26. Nies AS, Robertson D, Stone WJ. Hemodialysis hypotension is not the result of uremic peripheral autonomic neuropathy. J Lab Clin Med 1979; 94: 395–402.
27. Lake CR, Ziegler MG, Coleman MD, Kopin IJ. Plasma levels of norepinephrine and dopamine-β-hydroxylase in CRF patients treated with dialysis. Cardiovasc Med 1979; 4: 1099–111.
28. Corder CN, Sharma J, McDonald RH Jr. Variable levels of plasma catecholamines and dopamine β-hydroxylase in hemodialysis patients. Nephron 1980; 25: 267–72.
29. Textor SC, Gavras H, Tifft CP, Bernard DB, Idelson B, Brunner HR. Norepinephrine and renin activity in chronic renal failure: evidence for interacting roles in hemodialysis hypertension. Hypertension 1981; 3: 294–9.
30. Ziegler MG, Kennedy B, Morrissey E, O'Connor DT. Norepinephrine clearance, chromogranin A and dopamine β-hydroxylase in renal failure. Kidney Int 1990; 37: 1357–62.
31. Heidbreder E, Schafferhans K, Gotz R, Bausewein K, Heidland A. Plasma catecholamines in renal failure. Contrib Nephrol 1986; 50: 14–27.
32. Smogorzewski M, Campese VM, Massry SG. Abnormal norepinephrine uptake and release in brain synaptosomes in chronic renal failure. Kidney Int 1989; 36: 458–65.
33. Schaefer RM, Leschke M, Strauer BE, Heidland A. Blood rheology and hypertension in hemodialysis patients treated with erythropoietin. Am J Nephrol 1988; 8: 449–53.
34. Wallin BG, Delius W, Hagbarth K-E. Comparison of sympathetic nerve activity in normotensive and hypertensive subjects. Circ Res 1973; 33: 9–21.
35. Wallin BG, Sundlöf G. A quantitative study of muscle nerve sympathetic activity in resting normotensive and hypertensive subjects. Hypertension 1979; 1: 67–77.
36. Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990; 323: 693–9.
37. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 1989; 14: 177–83.
38. Mark AL, Mancia G. Cardiopulmonary baroreflexes in humans. In: Shepherd JT, Abboud FM, eds. Handbook of physiology: a critical, comprehensive presentation of physiological knowledge and concepts. Section 2, The cardiovascular system. Vol. 3. Peripheral circulation and organ blood flow, part 2. Bethesda, Md.: American Physiological Society, 1983:795–813.
39. Stein RD, Stephenson RB, Weaver LC. Central actions of angiotensin II oppose baroreceptor-induced sympathoinhibition. Am J Physiol 1984; 246: R13–R19.
40. Ferrario CM, Gildenberg PL, McCubbin JW. Cardiovascular effects of angiotensin mediated by the central nervous system. Circ Res 1972; 30: 257–62.